CYP2D6 polymorphism in systemic lupus erythematosus patients.

Abstract:

OBJECTIVES:To determine whether patients with idiopathic systemic lupus erythematosus (SLE) are associated with impaired CYP2D6 activity and to gain insight into whether there is an association between particular CYP2D6 genotypes and susceptibility to SLE, and whether CYP2D6 polymorphism is linked to any specific clinical features of SLE. METHODS:Debrisoquine sulfate (10 mg p.o.) was given to 159 healthy volunteers and 39 idiopathic SLE patients. Genotypic assay was carried out in 80 healthy volunteers and 32 patients. A 10-ml blood sample was drawn for genotypic assay. Debrisoquine and 4-hydroxydebrisoquine were determined in 8-h urine samples. Blood samples were analysed for the presence of mutations in the CYP2D6 gene, by using polymerase chain reaction (PCR) specific for CYP2D6*3 and CYP2D6*4 alleles. RESULTS:The metabolic ratio of debrisoquine to 4-hydroxydebrisoquine ranged from 0.01 to 86.98 in healthy subjects and from 0.02 to 96 in SLE patients. We observed the poor metabolizer(PM) debrisoquine phenotype in three of 39 patients with idiopathic SLE (7.6%) and five of 159 healthy subjects (3.1%). There was no significant difference in the frequency of PM phenotypes between idiopathic SLE and healthy subjects (Fisher's exact test, P = 0.19). No significant difference in the distribution of overall genotypes and allele frequencies were observed between the two groups. No significant relationships were found between specific clinical features and the overall genotype. CONCLUSION:The results of this study confirm that CYP2D6 activity is not impaired in SLE and that there is no association between SLE and phenotypic CYP2D6 status. The results also showed that there was no difference in the frequency of CYP2D6A and CYP2D6B alleles between controls and patients with SLE.

journal_name

Eur J Clin Pharmacol

authors

Kortunay S,Bozkurt A,Bathum L,Basci NE,Calgüneri M,Brøsen K,Kayaalp SO

doi

10.1007/s002280050587

subject

Has Abstract

pub_date

1999-03-01 00:00:00

pages

21-5

issue

1

eissn

0031-6970

issn

1432-1041

journal_volume

55

pub_type

临床试验,杂志文章
  • Drug-associated non-pyrogenic hyperthermia: a narrative review.

    abstract:PURPOSE:Hyperthermia occurs when heat accumulation surpasses the body's ability for heat dissipation. Many drugs may affect thermoregulation. This narrative review aimed to provide an overview of the current literature concerning reports of drug-associated non-pyrogenic hyperthermia. METHODS:A comprehensive search was...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s00228-019-02763-5

    authors: Bongers KS,Salahudeen MS,Peterson GM

    更新日期:2020-01-01 00:00:00

  • Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man.

    abstract:OBJECTIVE:The pharmacokinetics of orally and intravenously administered valsartan were determined in two studies. In a first pilot study, three i.v. doses of valsartan were given in an ascending manner (5, 10 and 20 mg) to evaluate tolerability and basic pharmacokinetics of the i.v. formulation. In a second study, the ...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s002280050259

    authors: Flesch G,Müller P,Lloyd P

    更新日期:1997-01-01 00:00:00

  • Population pharmacokinetics of domperidone in preterm neonates.

    abstract:PURPOSE:A population pharmacokinetic analysis was performed to define domperidone pharmacokinetic parameters in preterm neonates, as no pharmacokinetic data are available in this population. METHODS:An oral domperidone solution was administered (0.75 mg/kg per day) in 32 preterm neonates (64 samples). Domperidone plas...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-008-0535-1

    authors: Dailly E,Drouineau MH,Gournay V,Rozé JC,Jolliet P

    更新日期:2008-12-01 00:00:00

  • The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.

    abstract:AIM:Our aim was to characterize utilization patterns for drugs used to treat attention deficit/hyperactivity disorder (ADHD) on the level of the individual patient among Danish users, focusing on treatment duration, doses used, and concurrent use of ADHD and non-ADHD drugs. METHODS:Using the Danish Registry of Medicin...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-012-1344-0

    authors: Pottegård A,Bjerregaard BK,Glintborg D,Kortegaard LS,Hallas J,Moreno SI

    更新日期:2013-03-01 00:00:00

  • Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension.

    abstract::Twenty three patients with essential hypertension who were uncontrolled on diuretic and/or beta-receptor antagonist therapy were treated additionally with the vasodilator, pinacidil, in an open study. Significant reduction in mean blood pressure was achieved. Supine and erect systolic and diastolic blood pressure fell...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00543335

    authors: D'Arcy V,Laher M,McCoy D,Sullivan P,Walsh CH,Hickey MP

    更新日期:1985-01-01 00:00:00

  • Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium.

    abstract::The linearity of the pharmacokinetics of the metamizol metabolites 4-methyl-amino-antipyrine (4-MAA), 4-amino-antipyrine (4-AA), 4-formyl-aminoantipyrine (4-FAA), and 4-acetyl-amino-antipyrine (4-AcAA) has been studied after administration to 15 healthy male volunteers of single oral doses of 750, 1500, and 3000 mg me...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00314805

    authors: Vlahov V,Badian M,Verho M,Bacracheva N

    更新日期:1990-01-01 00:00:00

  • Influence of smoking and gender on the disposition kinetics of metoprolol.

    abstract::The purpose of this study was to examine the influence of cigarette smoking and gender on the pharmacokinetics of metoprolol. Eighteen volunteers with no evidence of clinical disease each randomly received the following doses of metoprolol tartrate: 100 mg orally, 200 mg orally and 20 mg as a constant-rate intravenous...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00637630

    authors: Schaaf LJ,Campbell SC,Mayersohn MB,Vagedes T,Perrier DG

    更新日期:1987-01-01 00:00:00

  • Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?

    abstract:PURPOSE:Neuroblastoma is the most common extracranial solid tumour in childhood. It accounts for 15% of all paediatric oncology deaths. In the last few decades, improvement in treatment outcome for high-risk patients has not occurred, with an overall survival rate <30-40%. Many reasons may account for such a low surviv...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s00228-010-0966-3

    authors: Bellanti F,Kågedal B,Della Pasqua O

    更新日期:2011-05-01 00:00:00

  • Acute effect of prednisone and deflazacort on glucose tolerance in prediabetic subjects.

    abstract::The diabetogenic effect of deflazacort (DF), an oxazolinic synthetic corticosteroid, was studied in 12 healthy adult subjects with a positive family history of diabetes mellitus. Three oral glucose tests (oGTT) were performed at 9.00 a.m., after a 12 h fast, following randomized administration of Placebo (PL), or Defl...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00542555

    authors: Pagano G,Lombardi A,Ferraris GM,Imbimbo B,Cavallo Perin P

    更新日期:1982-01-01 00:00:00

  • Biperiden effects and plasma levels in volunteers.

    abstract::The pharmacokinetics of biperiden was studied and compared with pharmacodynamics (pupil size, accommodation, self-rating mood scale) in 6 healthy volunteers. A single-blind cross-over design was employed with placebo and biperiden (4 mg as commercially available tablets). After a lag time of 0.5 h, biperiden was rapid...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00556903

    authors: Hollmann M,Brode E,Greger G,Müller-Peltzer H,Wetzelsberger N

    更新日期:1984-01-01 00:00:00

  • Identification of Dutch children diagnosed with atopic diseases using prescription data: a validation study.

    abstract:PURPOSE:The aim of this study is to validate medication proxies for the identification of children diagnosed with atopic disorders that can be applied in various types of epidemiological research. METHODS:Records of 7439 children, aged between 0 and 10 years, in the period 2001 until 2010, were retrieved from the Regi...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-015-1940-x

    authors: Mulder B,Groenhof F,Kocabas LI,Bos HJ,De Vries TW,Hak E,Schuiling-Veninga C

    更新日期:2016-01-01 00:00:00

  • Dose finding by concentration-response versus dose-response: a simulation-based comparison.

    abstract:AIM:The investigations reported here aimed to evaluate the incremental benefit for dose finding by concentration-response analysis versus dose-response analysis. METHODS:Trials were simulated using an Emax model for a range of scenarios of drug properties, trial design options and target response levels. The simulated...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-013-1474-z

    authors: Berges A,Chen C

    更新日期:2013-07-01 00:00:00

  • Comparison of parameters of in vitro lymphocyte beta 2-adrenoceptor function in normal and asthmatic subjects.

    abstract::There is conflicting data in the literature as to whether subsensitivity of in-vivo beta 2-adrenoceptor (beta 2-AR) responses in patients with asthma is due to an endogenous defect of beta 2-AR or an effect of exogenous beta 2-agonist therapy. The purpose of the study was to compare in-vitro parameters of lymphocyte b...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00315310

    authors: Newnham DM,Coutie WJ,McFarlane LC,Lipworth BJ

    更新日期:1993-01-01 00:00:00

  • Population pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder.

    abstract:PURPOSE:Lithium (Li), the first-line treatment of bipolar disorder, was first developed as an immediate-release form with a routine therapeutic drug monitoring 12 h after the last dose. In Europe, the most commonly prescribed form is a sustained release (srLi). Yet no pharmacokinetics (PK) study has been published of s...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-018-2605-3

    authors: Couffignal C,Bertrand J,Sportiche S,Jarroir M,El Balkhi S,Djebrani-Oussedik N,Poupon J,Declèves X,Mentré F,Bellivier F

    更新日期:2019-04-01 00:00:00

  • Pharmacokinetic interactions of alcohol and acetylsalicylic acid.

    abstract::This study assessed the influence of acetylsalicylic acid (ASA, 1.0 g), ibuprofen (0.8 g) and paracetamol (1.0 g) on the single-dose kinetics of ethanol in 12 healthy volunteers ingesting the drug and a standardised 1840-kJ breakfast 1 h before intake of ethanol. It also assessed the influence of ethanol on the single...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00192741

    authors: Melander O,Lidén A,Melander A

    更新日期:1995-01-01 00:00:00

  • Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol.

    abstract::Pharmacokinetic and pharmacodynamic properties of a new controlled-release (CR) formulation of metoprolol have been compared with those of atenolol. Metoprolol CR (100 mg and 200 mg), atenolol (50 mg and 100 mg) and placebo were each given once daily for four days in a double-blind, cross-over study to ten healthy men...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF00578408

    authors: Blomqvist I,Westergren G,Sandberg A,Jonsson UE,Lundborg P

    更新日期:1988-01-01 00:00:00

  • A preliminary study of the pharmacodynamics and pharmacokinetics of a novel enkephalin analogue [Tyr-D.Arg-Gly-Phe (4NO2).Pro.NH2 (BW443C)] in healthy volunteers.

    abstract::We have studied 16 healthy men to evaluate preliminary pharmacodynamics and kinetics of BW443C given by i.v. infusions. Four volunteers received escalating doses at weekly intervals, starting at 0.1 microgram.kg-1 for 60 min and increasing to a maximum of 2.0 micrograms.kg-1.min-1 for 180 min. Subsequently 12 differen...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF01061420

    authors: Posner J,Dean K,Jeal S,Moody SG,Peck AW,Rutter G,Telekes A

    更新日期:1988-01-01 00:00:00

  • Effect of probenecid on isofezolac kinetics.

    abstract::The interaction between isofezolac and probenecid has been studied with the aid of a specific HPLC assay for isofezolac in plasma and urine. 8 healthy adult volunteers received a single 40 mg oral dose of isofezolac before and after 3 days of loading with 0.5 probenecid t.i.d. There was an increase in the maximum plas...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00544363

    authors: Bannier A,Comet F,Soubeyrand J,Brazier JL,Chauliac F

    更新日期:1985-01-01 00:00:00

  • Corticosteroid therapy and need for hospital care in wheezing preschool children.

    abstract:OBJECTIVES:To study the frequency of corticosteroid therapy and the use of inpatient care for preschool children with wheezing in two regions in Finland. METHODS:The Finnish Social Insurance Institution database on refundable asthma medication indicated that 1.18% of children in Tampere and 2.37% in Turku used inhaled...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s002280000199

    authors: Csonka P,Mertsola J,Klaukka T,Kaila M,Ståhlberg MR,Ashorn P

    更新日期:2000-11-01 00:00:00

  • Drug safety in pregnancy: the German Embryotox institute.

    abstract::Since 1988, the German Embryotox institute combines individual counselling of pregnant women and their health care providers (HCP) with research on drug safety in pregnancy. In addition, Embryotox offers web-based information which covers the most important and most frequently requested pharmaceutical substances. In c...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-017-2351-y

    authors: Dathe K,Schaefer C

    更新日期:2018-02-01 00:00:00

  • Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol.

    abstract::Atenolol 100 mg and penbutolol 40 mg given once a day were both effective in controlling moderate hypertension, as judged by a randomised controlled, double-blind trial in 45 patients treated for six weeks. Both drugs significantly reduced the resting supine and erect blood pressures. No serious adverse effects could ...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00637507

    authors: Lameijer LD,Voermans LA,Houtzagers JJ,Chadha DR

    更新日期:1981-01-01 00:00:00

  • Experimental, extrapolated and truncated areas under the concentration-time curve in bioequivalence trials.

    abstract:OBJECTIVE:The extrapolated area under the concentration-time curve (AUC0-infinity) for any drug is considered by operating guidelines as the primary parameter related to the extent of absorption in single-dose bioavailability and bioequivalence trials. Not more than 20% should be added to the experimental AUC (AUC0-t) ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s002280050684

    authors: Marzo A,Monti NC,Vuksic D

    更新日期:1999-11-01 00:00:00

  • Real-time RT-PCR methodology for quantification of thiopurine methyltransferase gene expression.

    abstract:OBJECTIVE:The aim of the present study was to develop a real-time reverse-transcription polymerase chain reaction (RT-PCR) methodology for the quantification of thiopurine methyltransferase (TPMT) gene expression in whole blood and compare it with the TPMT enzyme activity measured in red blood cells. METHODS:TPMT gene...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-003-0617-z

    authors: Lindqvist M,Almer S,Peterson C,Söderkvist P

    更新日期:2003-07-01 00:00:00

  • The excretion of ketorolac tromethamine into breast milk after multiple oral dosing.

    abstract::We have studied the transfer of the analgesic ketorolac tromethamine into breast milk in ten women aged between 22 and 35 years. Ketorolac administration was started between 2 and 6 days after delivery. The breast milk was not fed to the infant because of maternal antibiotic use (6 patients) or because of jaundice of ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00558080

    authors: Wischnik A,Manth SM,Lloyd J,Bullingham R,Thompson JS

    更新日期:1989-01-01 00:00:00

  • Underuse of lipid-lowering drugs and factors associated with poor adherence: a real practice analysis in Italy.

    abstract:BACKGROUND:Many studies have indicated the adequate use of lipid-lowering drugs (LLDs) as a factor in reducing the risk of cardiovascular disease. However, in clinical practice, a very high percentage of patients are not adequately treated. OBJECTIVE:To analyze the management of hypercholesterolemia in a non-experimen...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-005-0911-z

    authors: Di Martino M,Degli Esposti L,Ruffo P,Bustacchini S,Catte A,Sturani A,Degli Esposti E

    更新日期:2005-05-01 00:00:00

  • Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated alleles.

    abstract:OBJECTIVES:Administration of fluvoxamine (FLV) with concomitant benzodiazepines is common in clinical situations. We studied the effects of the coadministration of FLV on plasma concentrations of alprazolam (ALP). We also studied the effects of CYP2C19(*)2 or CYP2C19(*)3 on these drug interactions. METHODS:The subject...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-003-0563-9

    authors: Suzuki Y,Shioiri T,Muratake T,Kawashima Y,Sato S,Hagiwara M,Inoue Y,Shimoda K,Someya T

    更新日期:2003-04-01 00:00:00

  • Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine.

    abstract::Dexmedetomidine is a novel alpha 2-adrenoceptor agonist that may provide beneficial effects as premedication for anesthesia. The pharmacokinetics and pharmacodynamics of transdermal (TD) and intravenous (i.v.) dexmedetomidine were studied in nine healthy male subjects in a crossover trial. The TD preparation, containi...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00194403

    authors: Kivistö KT,Kallio A,Neuvonen PJ

    更新日期:1994-01-01 00:00:00

  • Methylergometrine antagonizes 5 HT in the temporal artery.

    abstract::Methylergometrine, the main metabolite of methysergide, has 40-times greater 5 HT antagonistic potency than methysergide in isolated segments of human temporal artery. It is suggested that methylergometrine is the "active" drug when methysergide is used in migraine prophylaxis, and that the two compounds should be com...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00610384

    authors: Tfelt-Hansen P,Jansen I,Edvinsson L

    更新日期:1987-01-01 00:00:00

  • Erythropoetin as a novel agent with pleiotropic effects against acute lung injury.

    abstract::Current pharmacotherapy for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is not optimal, and the biological and physiological complexity of these severe lung injury syndromes requires consideration of combined-agent treatments or agents with pleiotropic action. In this regard, exogenous eryth...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s00228-010-0938-7

    authors: Kakavas S,Demestiha T,Vasileiou P,Xanthos T

    更新日期:2011-01-01 00:00:00

  • Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function.

    abstract::The effect of a single oral dose of 40 mg xipamide on urinary excretion of Na+, K+, Cl-, Ca2+ and Mg2+ in healthy subjects and in patients with varying degrees of renal impairment was compared with various conventional diuretics. Xipamide caused marked excretion of Na+ and Cl-, whereas the diuretic produced only moder...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00542150

    authors: Knauf H,Mutschler E

    更新日期:1984-01-01 00:00:00